Tower Research Capital (TRC)’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-9,111
| Closed | -$31K | – | 4739 |
|
|
2018
Q3 | $31K | Buy |
+9,111
| New | +$31K | ﹤0.01% | 2062 |
|
|
2018
Q1 | – | Sell |
-623
| Closed | -$3K | – | 4309 |
|
|
2017
Q4 | $3K | Sell |
623
-9,245
| -94% | -$44.5K | ﹤0.01% | 3153 |
|
|
2017
Q3 | $71K | Buy |
9,868
+7,629
| +341% | +$54.9K | 0.01% | 1676 |
|
|
2017
Q2 | $16K | Buy |
+2,239
| New | +$16K | ﹤0.01% | 1359 |
|
|
2017
Q1 | – | Sell |
-5,911
| Closed | -$35K | – | 4415 |
|
|
2016
Q4 | $35K | Buy |
+5,911
| New | +$35K | ﹤0.01% | 1684 |
|
|
2016
Q2 | – | Sell |
-3,430
| Closed | -$16K | – | 5330 |
|
|
2016
Q1 | $16K | Buy |
3,430
+3,200
| +1,391% | +$14.9K | ﹤0.01% | 1536 |
|
|
2015
Q4 | $1K | Sell |
230
-5,034
| -96% | -$21.9K | ﹤0.01% | 4272 |
|
|
2015
Q3 | $19K | Sell |
5,264
-3,359
| -39% | -$12.1K | ﹤0.01% | 1794 |
|
|
2015
Q2 | $86K | Buy |
8,623
+1,701
| +25% | +$17K | 0.01% | 968 |
|
|
2015
Q1 | $88K | Buy |
+6,922
| New | +$88K | 0.01% | 1004 |
|
|
2014
Q4 | – | Sell |
-1
| Closed | – | – | 5083 |
|
|
2014
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5177 |
|
|
2014
Q2 | – | Sell |
-19,984
| Closed | -$341K | – | 5003 |
|
|
2014
Q1 | $341K | Buy |
+19,984
| New | +$341K | 0.04% | 278 |
|
|
2013
Q4 | – | Sell |
-18,426
| Closed | -$186K | – | 5148 |
|
|
2013
Q3 | $186K | Buy |
+18,426
| New | +$186K | 0.02% | 801 |
|